La Jiao Feng Shi Gao

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to apply one or two plasters to the affected area once daily. The plasters should be removed after 12 hours of application.

For children aged 2 to 12 years and adults with compromised health, the use of plasters should only occur under the guidance of a healthcare professional.

The product is contraindicated for use in children under 2 years of age; consultation with a doctor is advised in such cases.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to wounds, as this may exacerbate the condition. It is also contraindicated for use on irritated or damaged skin due to the potential for further irritation or adverse reactions. If there is any change in the appearance of the product, it should not be used, as this may indicate degradation or contamination.

Application should not exceed 12 hours, as prolonged use may lead to adverse effects. Additionally, individuals with known hypersensitivities to this product must avoid its use to prevent allergic reactions. Finally, the product should only be used as directed; any deviation from the specified instructions is contraindicated.

Warnings and Precautions

For external use only, this product contains natural rubber latex, which may lead to allergic reactions in susceptible individuals. Healthcare professionals should be aware of this allergy alert when recommending this product to patients.

General precautions must be observed to ensure safe use. Contact with the eyes or mucous membranes should be strictly avoided. Additionally, it is important not to bandage the area tightly, as this may lead to complications. Supervision is advised when this product is used by children, and caution should be exercised in patients with a history of allergic reactions.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider under the following circumstances: if the condition worsens; if symptoms persist for more than 7 days; if symptoms resolve and then recur within a few days; if excessive skin irritation develops; if used for arthritis pain and the pain persists for more than 10 days; if redness is observed; or if the product is being used in children under 12 years of age.

Side Effects

Patients using this product should be aware of potential adverse reactions, including the risk of allergic reactions due to the presence of natural rubber latex. Individuals with a known allergy to latex may experience serious allergic responses.

Participants are advised to discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, excessive skin irritation develops, or if the product is used for arthritis pain and the pain persists for more than 10 days. Additionally, patients should seek medical advice if redness is present or if the product is being used in children under 12 years of age.

These precautions are essential to ensure the safety and well-being of patients while using this product.

Drug Interactions

Patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication if they are currently taking other medications. This precaution is essential to avoid potential drug interactions that may affect the efficacy or safety of the treatment.

There are no specific laboratory test interactions reported for this medication. Therefore, routine laboratory monitoring is not indicated based on the available data. However, it remains important for healthcare providers to consider the overall medication regimen of the patient to ensure comprehensive care.

Packaging & NDC

Below are the non-prescription pack sizes of La Jiao Feng Shi Gao (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be supervised during the use of this medication. For children aged 2 to 12 years and adults with compromised health, administration should occur only under the guidance of a healthcare professional. The use of this medication is not recommended for children under 2 years of age; consultation with a doctor is advised in such cases. Caution is warranted in conditions affecting children under 12 years of age.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication. The potential risks and benefits should be carefully considered, as the effects on fetal outcomes are not fully established. Women of childbearing potential should exercise caution and seek medical advice to ensure the safety of both themselves and their developing fetus.

Lactation

Lactating mothers should not use this medication if they are pregnant. It is advised that lactating mothers consult with a doctor or pharmacist before using this medication to ensure safety for both themselves and their breastfed infants. There is no specific data provided regarding excretion in breast milk or effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Healthcare professionals are advised to monitor the patient closely and provide supportive care as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Patients should be instructed to apply the product only on wounds or on irritated or damaged skin, and to refrain from use if the appearance of the product has changed.

It is important to inform patients that the product should not be used for longer than 12 hours unless directed otherwise. Patients with known hypersensitivities to the product should be cautioned against its use. They should also be advised to use the product strictly as directed and to monitor their condition closely. If symptoms worsen or persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients should be encouraged to consult their healthcare provider.

Patients should be made aware that excessive irritation of the skin may develop, particularly when using the product for arthritis pain. If pain persists for more than 10 days or if redness is present, they should seek medical advice. Special caution should be taken when using the product in children under 12 years of age, and healthcare providers should recommend that use be supervised by an adult.

Patients should be instructed to avoid contact with the eyes or mucous membranes and to avoid tightly bandaging the area where the product is applied. Those who are pregnant or taking other medications should discuss their situation with their healthcare provider before using the product. Additionally, patients prone to allergic reactions should use caution and consult their healthcare provider if they have any concerns.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored in a dry area at a temperature not exceeding 20 degrees Celsius (68 degrees Fahrenheit) to ensure optimal stability and efficacy.

Additional Clinical Information

The transdermal route of administration is indicated for patients aged 12 years and older, who should apply one or two plasters to the affected area once daily, removing them after 12 hours. For children aged 2 to 12 years and adults with compromised health, use should only occur under the guidance of a physician. The product is contraindicated for use in children under 2 years of age, and consultation with a doctor is advised in such cases.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for La Jiao Feng Shi Gao, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)